Jim Cramer advises against buying Eli Lilly stock, regrets recommending Nextracker, and doubts Trump Media & Technology Group.
In a recent "Lightning Round," Jim Cramer of "Mad Money" advised investors to hold off on buying Eli Lilly until its stock price decreases. He labeled his previous recommendation of Nextracker as a mistake and discouraged purchasing its stock. Cramer also expressed uncertainty about Trump Media & Technology Group, calling it an opaque company with insufficient information. He encourages following his market insights through the CNBC Investing Club.
October 24, 2024
4 Articles